We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+13.63%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$48.3B
AUM Growth
+$4.2B
Cap. Flow
-$749M
Cap. Flow %
-1.55%
Top 10 Hldgs %
25.22%
Holding
973
New
114
Increased
273
Reduced
385
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 25.57%
2 Healthcare 16.39%
3 Financials 11.55%
4 Consumer Discretionary 10.38%
5 Industrials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMG icon
351
Chipotle Mexican Grill
CMG
$42.7B
$26M 0.05%
567,700
-252,750
-31% -$10.5M
EWBC icon
352
East-West Bancorp
EWBC
$18.1B
$25.8M 0.05%
358,955
-504,664
-58% -$30.4M
FIVE icon
353
Five Below
FIVE
$12.8B
$25.6M 0.05%
120,000
+20,000
+20% +$3.67M
EPRT icon
354
Essential Properties Realty Trust
EPRT
$6.62B
$25.6M 0.05%
1,000,000
+450,000
+82% +$10.4M
HPQ icon
355
HP
HPQ
$25.8B
$25.4M 0.05%
844,736
+66,100
+8% +$1.85M
WST icon
356
West Pharmaceutical
WST
$24.5B
$25.3M 0.05%
71,907
-1,500
-2% -$531K
DAL icon
357
Delta Air Lines
DAL
$60.5B
$25.2M 0.05%
625,336
-14,700
-2% -$533K
MOD icon
358
Modine Manufacturing
MOD
$10.2B
$25.1M 0.05%
420,682
-59,436
-12% -$2.91M
OLLI icon
359
Ollie's Bargain Outlet
OLLI
$4.71B
$25M 0.05%
330,000
+120,000
+57% +$9.04M
BXP icon
360
Boston Properties
BXP
$11B
$24.8M 0.05%
354,097
-306,401
-46% -$18.1M
SYY icon
361
Sysco
SYY
$40.4B
$24.8M 0.05%
339,724
-162,500
-32% -$11.2M
MRNA icon
362
Moderna
MRNA
$21.5B
$24.8M 0.05%
249,453
-63,763
-20% -$5.36M
TTWO icon
363
Take-Two Interactive
TTWO
$43.5B
$24.7M 0.05%
153,660
+31,600
+26% +$4.71M
ZBH icon
364
Zimmer Biomet
ZBH
$18.5B
$24.7M 0.05%
203,042
-4,700
-2% -$524K
AUTL
365
Autolus Therapeutics
AUTL
$532M
$24.6M 0.05%
+3,825,532
New +$14.6M
PTCT icon
366
PTC Therapeutics
PTCT
$5.91B
$24.6M 0.05%
892,238
+742,238
+495% +$17M
RMD icon
367
ResMed
RMD
$32.4B
$24.6M 0.05%
142,884
+66,442
+87% +$10.2M
WBD icon
368
Warner Bros
WBD
$66.2B
$24.5M 0.05%
2,155,543
-1,477,905
-41% -$16M
SRRK icon
369
Scholar Rock
SRRK
$6.41B
$24.4M 0.05%
+1,300,000
New +$16.2M
HSY icon
370
Hershey
HSY
$36.8B
$24.3M 0.05%
130,585
+41,600
+47% +$7.88M
NWSA icon
371
News Corp Class A
NWSA
$16B
$24.1M 0.05%
980,248
-59,000
-6% -$1.28M
HST icon
372
Host Hotels & Resorts
HST
$16B
$24M 0.05%
1,235,233
-272,300
-18% -$4.67M
RVTY icon
373
Revvity
RVTY
$12.7B
$24M 0.05%
219,888
+156,500
+247% +$15.1M
THC icon
374
Tenet Healthcare
THC
$20.7B
$24M 0.05%
+317,168
New +$20.1M
ACHC icon
375
Acadia Healthcare
ACHC
$2.86B
$23.9M 0.05%
+307,330
New +$22.7M

Similar funds

Adage Capital Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Adage Capital Partners held 973 positions worth $48.3B, up 9.5% from $44.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Adage Capital Partners's Q4 2023 filing shows 114 new, 273 increased, 385 reduced and 131 closed positions. Its largest new stake was Uber: 2,148,900 shares worth $132M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q4 2023 buy was Uber: 2,148,900 shares worth $132M.
  • Adage Capital Partners added most to Hess in Q4 2023, an estimated $516M increase.
  • Adage Capital Partners's biggest Q4 2023 reduction was lululemon athletica, cutting an estimated $124M.
  • Adage Capital Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $340M.
  • Adage Capital Partners's ten largest holdings make up 25% of its $48.3B portfolio in Q4 2023.
  • Adage Capital Partners opened 114 new positions and closed 131 in Q4 2023.
  • Adage Capital Partners's portfolio value rose 9.5% quarter-over-quarter to $48.3B.

Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.